Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Safety of benzodiazepines in newborns
Eugene Ng
*
,
Gil Klinger
, Vibhuti Shah
, Anna Taddio
, Annette Pérez
, Louise Gagnon
*
Corresponding author for this work
University of Toronto
Research output
:
Contribution to journal
›
Article
›
peer-review
53
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Safety of benzodiazepines in newborns'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Drug Reaction
16%
Adverse Effects
83%
Adverse Events
16%
Analgesic
16%
Anecdotal Evidence
16%
Anticonvulsant
33%
Benzodiazepine Dependence
33%
Benzodiazepines
100%
Birth Weight
16%
Concomitant Drug Use
16%
Concomitant Use
16%
Drug Administration
16%
Full-term Infants
33%
Gestational Age
16%
Hypotension
33%
Illness
16%
Inotropes
33%
Lorazepam
16%
Median Range
16%
Midazolam
16%
Morphine
16%
Multiple Drugs
16%
Neonatal Intensive Care Unit
16%
Postnatal Age
16%
Preterm Infants
16%
Probability Scale
16%
Reaction Probability
16%
Respiratory Depression
33%
Retrospective Chart Review
16%
Risk-benefit Ratio
16%
Sedation
16%
Sedative
16%
Seizure
33%
Serious Adverse Effects
16%
Underlying Medical Conditions
16%
Ventilatory Support
16%
Vulnerable Populations
16%
Medicine and Dentistry
Adverse Drug Reaction
16%
Adverse Effect
100%
Adverse Event
16%
Anticonvulsant
33%
Benzodiazepine
50%
Benzodiazepine Derivative
100%
Birth Weight
16%
Concomitant Drug
16%
Diseases
16%
Drug Administration
16%
Drug Use
16%
Epileptic Seizure
33%
Gestational Age
16%
Hypotension
33%
Inotropic Agent
33%
Lorazepam
16%
Midazolam
16%
Morphine
16%
Neonatal Infant
100%
Neonatal Intensive Care Unit
16%
Respiration Depression
33%
Sedative Agent
16%
Vulnerable Population
16%